The octapeptide angiotensin II (Ang II) has long been recognized as a key component in the neuroendocrine control of cardiovascular function. Ang II also plays an important role in the development of oocytes in both amphibians and mammals. Angiotensin II exerts its effects by binding to its high affinity receptors AT1 and AT2. Both of these receptors share seven-transmembrane domain topology and 34% amino acid identity. The responses induced by the AT2 receptor are sensitive to pertussis toxin suggesting that this receptor is a Gi-protein-coupled receptor. However, this receptor does not demonstrate the GTP-gamma induced shift to a low affinity form that is characteristic of the G-protein-linked receptors. Therefore it was suggested that this receptor mediates its effects through a non-classical, Gi type G-protein. The long-term objectives of the research in this laboratory are: a) to understand how the ligand-induced responses of a cell are regulated, and b) to elucidate how the receptor-mediated signal transduction regulates the molecular switch that determines the fate (growth or apoptosis) of a cell. The primary objective of this proposal is to analyze the structure-function relationship of rat AT2 receptor and to elucidate what are the intracellular signaling cascades that are activated in response to the binding of Ang II to this receptor when expressed in Xenopus oocytes. Our recent findings indicate that activation of rat AT2 receptor expressed in Xenopus oocytes causes an elevation in the intracellular IP3 levels. However, Ang II binding to rat AT2 receptors expressed in Xenopus oocytes causes an elevation in the intracellular IP3 levels. However, Ang II binding to rat AT2 receptors expressed in Xenopus oocytes is not sensitive to GTPgammaS. Therefore, the PI hypothesizes that the rat AT2 receptor mediated activation of the phospholipase C pathway in Xenopus oocytes is also effected through a non-classical Gi-protein endogenous to these cells. Experiments are directed to identify and characterize the nature of this endogenous mediator that couples rat AT2 receptor to PLC pathway. To do this, the PI proposes to study the structure-function relationship of AT2 receptor by generating site-directed mutants and AT2:AT1 chimeric proteins. The PI also proposes to analyze what other signaling mechanisms are activated by rat AT2 receptor in Xenopus oocytes. The PI hopes these studies will provide new insights into the signaling by AT2 receptor and its possible role in oocyte development.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15HL060241-01
Application #
2613040
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1998-09-04
Project End
2002-08-31
Budget Start
1998-09-04
Budget End
2002-08-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Bowling Green State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
617407325
City
Bowling Green
State
OH
Country
United States
Zip Code
43403
Gul, Rukhsana; Ramdas, Maya; Mandavia, Chirag H et al. (2012) RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches. Cardiorenal Med 2:268-280
Pulakat, Lakshmi; Rahman, Simi; Gray, Amanda et al. (2005) Roles of the intracellular regions of angiotensin II receptor AT2 in mediating reduction of intracellular cGMP levels. Cell Signal 17:395-404
Pulakat, Lakshmi; Cooper, Shannon; Knowle, Dieter et al. (2005) Ligand-dependent complex formation between the Angiotensin II receptor subtype AT2 and Na+/H+ exchanger NHE6 in mammalian cells. Peptides 26:863-73
Pulakat, Lakshmi; Mandavia, Chirag H; Gavini, Nara (2004) Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling. Biochem Biophys Res Commun 319:1138-43
Pulakat, Lakshmidevi; Gray, Amanda; Johnson, Janean et al. (2002) Role of C-terminal cytoplasmic domain of the AT2 receptor in ligand binding and signaling. FEBS Lett 524:73-8
Kumar, Vikas; Knowle, Dieter; Gavini, Narasaiah et al. (2002) Identification of the region of AT2 receptor needed for inhibition of the AT1 receptor-mediated inositol 1,4,5-triphosphate generation. FEBS Lett 532:379-86
Knowle, D; Kurfis, J; Gavini, N et al. (2001) Role of Asp297 of the AT2 receptor in high-affinity binding to different peptide ligands. Peptides 22:2145-9
Knowle, D; Ahmed, S; Pulakat, L (2000) Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family. Regul Pept 87:73-82
Dittus, J; Cooper, S; Obermair, G et al. (1999) Role of the third intracellular loop of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. FEBS Lett 445:23-6
Turner, C A; Cooper, S; Pulakat, L (1999) Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. Biochem Biophys Res Commun 257:704-7

Showing the most recent 10 out of 11 publications